Blazar et al. found that anti-PD-1 antibodies have a higher risk of causing graft-versus-host disease than anti-CTLA-4 and that the combination leads to more severe graft-versus-host disease [59]. This evidence concerns the gene CTLA4 and graft versus host disease.